Concourse Financial Group Securities, Inc. Pro Phase Labs, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$2.16 - $4.06 $0 - $0	0 New	0 $0
Q2 2024 Jul 23, 2024	SELL	$4.18 - $7.35 $1,220 - $2,146	-292 Closed	0 $0
Q1 2023 May 15, 2023	SELL	$6.62 - $9.57 $3,250 - $4,698	-491 Reduced 62.71%	292 $2,000
Q4 2022 Jan 30, 2023	SELL	$8.78 - $12.47 $24,575 - $34,903	-2,799 Reduced 78.14%	783 $0
Q3 2022 Nov 15, 2022	SELL	$8.96 - $14.7 $28,591 - $46,907	-3,191 Reduced 47.11%	3,582 $40,000
Q2 2022 Aug 09, 2022	BUY	$6.52 - $13.24 $44,159 - $89,674	6,773 New	6,773 $86,000
Q1 2022 May 09, 2022	BUY	$6.2 - $7.87 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$5.13 - $7.89 $0 - $0	0 New	0 $0
Q3 2021 Nov 09, 2021	BUY	$4.89 - $7.82 $0 - $0	0 New	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.61 - $6.83 $0 - $0	0 New	0 $0
Q1 2021 May 13, 2021	BUY	$6.19 - $16.0 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	BUY	$3.9 - $11.25 $0 - $0	0 New	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.4 - $3.87 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.2 - $1.99 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$1.74 - $2.1 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.66 - $2.2 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$1.63 - $2.2 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.1 - $3.07 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$2.7 - $3.65 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.95 - $3.27 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$2.94 - $3.23 $0 - $0	0 New	0 $0

Others Institutions Holding PRPH

# of Institutions

Shares Held

1.96M

Call Options Held

Put Options Held

View Full List

About ProPhase Labs, Inc.

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $3.85M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

More about PRPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account